NI
AKBA icon

Numeric Investors’s Akebia Therapeutics AKBA Stock Holding History

Numeric Investors’s Portfolio AKBA Stock Details AKBA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$3.25M Sell
218,219
-158,855
-42% -$2.63M 0.02% 518
2017
Q3 		$7.42M Sell
377,074
-244,893
-39% -$3.77M 0.06% 312
2017
Q2 		$8.94M Buy
+621,967
New +$7.88M 0.08% 234

Other funds holding AKBA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Numeric Investors's AKBA Position: Q4 2017 in Review

Numeric Investors reduced its Akebia Therapeutics (AKBA) stake by 42% in Q4 2017, selling an estimated $2.63M and leaving 218,219 shares worth $3.25M. The position accounts for 0.02% of the portfolio, ranked #518.

Numeric Investors first reported a position in AKBA in Q2 2017 and has held it in 3 quarters since. The position peaked at $8.94M in Q2 2017. 132 funds tracked by Wall St. Rank hold AKBA as of Q4 2017.

  • Numeric Investors held 218,219 shares of Akebia Therapeutics worth $3.25M as of Q4 2017.
  • Numeric Investors sold 158,855 Akebia Therapeutics shares in Q4 2017, an estimated $2.63M.
  • Akebia Therapeutics made up 0.02% of Numeric Investors's portfolio in Q4 2017, its #518 holding.
  • Numeric Investors first reported a position in Akebia Therapeutics in Q2 2017 and has held it in 3 quarters since.
  • Numeric Investors's Akebia Therapeutics position peaked at $8.94M in Q2 2017.
  • 132 funds tracked by Wall St. Rank held Akebia Therapeutics as of Q4 2017.

Based on Numeric Investors's 13F filing for Q4 2017, filed 14 Feb 2018.